On the public citation graph
Hit and lead identification: Integrated technology-based approaches
0 signed · 88 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/3527603948.ch13openalex-snapshot
Navigation in Chemical Space: Ligand‐Based Design of Focused Compound Libraries
inferredcites →https://doi.org/10.1002/anie.200462798openalex-snapshot
Convergent Diversity‐Oriented Synthesis of Small‐Molecule Hybrids
inferredcites →https://doi.org/10.1006/abio.1999.4406openalex-snapshot
Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors
inferredcites →https://doi.org/10.1016/b978-0-12-374194-3.00022-6openalex-snapshot
Compound Properties and Drug Quality
inferredcites →https://doi.org/10.1016/b978-012744481-9/50025-8openalex-snapshot
COMPOUND PROPERTIES AND DRUG QUALITY
inferredcites →https://doi.org/10.1016/j.bmcl.2003.09.036openalex-snapshot
β-Alanine dipeptides as MC4R agonists
inferredcites →https://doi.org/10.1016/j.bmcl.2004.03.058openalex-snapshot
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
inferredcites →https://doi.org/10.1016/j.cbpa.2005.05.002openalex-snapshot
Fragonomics: fragment-based drug discovery
inferredcites →https://doi.org/10.1016/j.cbpa.2005.06.007openalex-snapshot
Recent applications of protein crystallography and structure-guided drug design
inferredcites →https://doi.org/10.1016/j.chembiol.2004.03.022openalex-snapshot
Structural Determinants of CDK4 Inhibition and Design of Selective ATP Competitive Inhibitors
inferredcites →https://doi.org/10.1016/j.jmgm.2004.03.006openalex-snapshot
Selecting compounds for focused screening using linear discriminant analysis and artificial neural networks
inferredcites →https://doi.org/10.1016/s0065-7743(04)39020-2openalex-snapshot
Comparative Protein Structure Modeling and its Applications to Drug Discovery
inferredcites →https://doi.org/10.1016/s0065-7743(04)39022-6openalex-snapshot
The Hit-to-Lead Process in Drug Discovery
inferredcites →https://doi.org/10.1016/s0079-6565(02)00049-3openalex-snapshot
NMR screening techniques in drug discovery and drug design
inferredcites →https://doi.org/10.1016/s0196-9781(96)00141-6openalex-snapshot
Truncation Studies of ?-Melanotropin Peptides Identify Tripeptide Analogues Exhibiting Prolonged Agonist Bioactivity
inferredcites →https://doi.org/10.1016/s1074-5521(03)00095-4openalex-snapshot
Multidimensional Chemical Genetic Analysis of Diversity-Oriented Synthesis-Derived Deacetylase Inhibitors Using Cell-Based Assays
inferredcites →https://doi.org/10.1016/s1359-6446(05)03484-7openalex-snapshot
Keynote review: Structural biology and drug discovery
inferredcites →https://doi.org/10.1016/s1367-5931(03)00059-0openalex-snapshot
Lead compounds discovered from libraries: Part 2
inferredcites →https://doi.org/10.1021/ac0006270openalex-snapshot
MS/NMR: A Structure-Based Approach for Discovering Protein Ligands and for Drug Design by Coupling Size Exclusion Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy
inferredcites →https://doi.org/10.1021/ja017830copenalex-snapshot
Structure-Based Screening As Applied to Human FABP4: A Highly Efficient Alternative to HTS for Hit Generation
inferredcites →https://doi.org/10.1021/jm00120a002openalex-snapshot
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
inferredcites →https://doi.org/10.1021/jm00382a001openalex-snapshot
Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase
inferredcites →https://doi.org/10.1021/jm00394a033openalex-snapshot
.alpha.-Melanotropin: the minimal active sequence in the frog skin bioassay
inferredcites →https://doi.org/10.1021/jm010533yopenalex-snapshot
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
inferredcites →https://doi.org/10.1021/jm0502900openalex-snapshot
Are Target-Family-Privileged Substructures Truly Privileged?
inferredcites →https://doi.org/10.1021/jm0504555openalex-snapshot
Structure-Based Design and Discovery of Protein Tyrosine Phosphatase Inhibitors Incorporating Novel Isothiazolidinone Heterocyclic Phosphotyrosine Mimetics
inferredcites →https://doi.org/10.1021/jm0510979openalex-snapshot
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies
inferredcites →https://doi.org/10.1021/jm058241aopenalex-snapshot
Melanocortin-4 Receptor (MC4R) Agonists for the Treatment of Obesity
inferredcites →https://doi.org/10.1021/np030096lopenalex-snapshot
Natural Products as Sources of New Drugs over the Period 1981−2002
inferredcites →https://doi.org/10.1038/416653aopenalex-snapshot
Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays
inferredcites →https://doi.org/10.1038/nbt1068openalex-snapshot
A small molecule–kinase interaction map for clinical kinase inhibitors
inferredcites →https://doi.org/10.1038/nchembio0705-74openalex-snapshot
Diversity-oriented synthesis: exploring the intersections between chemistry and biology
inferredcites →https://doi.org/10.1038/nchembio775openalex-snapshot
Virtual and biomolecular screening converge on a selective agonist for GPR30
inferredcites →https://doi.org/10.1038/sj.ijir.3901200openalex-snapshot
Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra®
inferredcites →https://doi.org/10.1073/pnas.77.7.3957openalex-snapshot
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
inferredcites →https://doi.org/10.1089/adt.2006.4.209openalex-snapshot
Application of Laser-Scanning Fluorescence Microplate Cytometry in High Content Screening
inferredcites →https://doi.org/10.1124/mol.105.014068openalex-snapshot
Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonists
inferredcites →https://doi.org/10.1194/jlr.m500388-jlr200openalex-snapshot
Automated microscopy screening for compounds that partially revert cholesterol accumulation in Niemann-Pick C cells
inferredcites →https://doi.org/10.1358/dof.2003.028.07.857183openalex-snapshot
From the combinatorial chemistry boom to polymer-supported parallel chemistry: established technologies for drug discovery
inferredcites →https://doi.org/10.2174/0929867023368728openalex-snapshot
Chemogenomics: Bridging a Drug Discovery Gap
inferredcites →https://doi.org/10.2174/1386207043328238openalex-snapshot
Molecular Diversity Management Strategies for Building and Enhancement of Diverse and Focused Lead Discovery Compound Screening Collections
inferredcites →https://doi.org/10.2174/1386207043328409openalex-snapshot
Quality, not Quantity: The Role of Natural Products and Chemical Proteomics in Modern Drug Discovery
inferredcites →https://doi.org/10.2174/1568026053828376openalex-snapshot
Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection
inferredcites →https://doi.org/10.2174/156802606775193347openalex-snapshot
Recent Developments in Focused Library Design: Targeting Gene-Families
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/9781118832738.ch18openalex-snapshot
The Changing Feasibility and Economics of Chemical Diversity Exploration with DNA‐Encoded Combinatorial Approaches
inferred← citeshttps://doi.org/10.1002/cpph.35openalex-snapshot
Binding Assays for Bromodomain Proteins: Their Utility in Drug Discovery in Oncology and Inflammatory Disease
inferred← citeshttps://doi.org/10.1002/jmr.726openalex-snapshot
Survey of the year 2003 commercial optical biosensor literature
inferred← citeshttps://doi.org/10.1002/jmr.862openalex-snapshot
Survey of the year 2006 commercial optical biosensor literature
inferred← citeshttps://doi.org/10.1002/minf.201200154openalex-snapshot
A Crowd‐Based Process and Tool for HTS Hit Triage
inferred← citeshttps://doi.org/10.1016/b978-0-12-819971-8.00019-6openalex-snapshot
Microfluidic systems for drug discovery, pharmaceutical analysis, and diagnostic applications
inferred← citeshttps://doi.org/10.1016/b978-0-12-822312-3.00010-2openalex-snapshot
Use of Molecular Docking as a Decision-Making Tool in Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-16013-4.00012-9openalex-snapshot
Fundamental approaches of drug discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-23932-8.00002-9openalex-snapshot
Target-based vs phenotypic drug discovery: opportunities and challenges with evidence-based application
inferred← citeshttps://doi.org/10.1016/bs.apha.2025.01.002openalex-snapshot
Essential database resources for modern drug discovery
inferred← citeshttps://doi.org/10.1016/j.ddtec.2006.12.007openalex-snapshot
Chemical diversity and biological activity
inferred← citeshttps://doi.org/10.1016/j.ddtec.2010.11.003openalex-snapshot
Ligand efficiency as a guide in fragment hit selection and optimization
inferred← citeshttps://doi.org/10.1016/j.ddtec.2013.01.004openalex-snapshot
Very large virtual compound spaces: construction, storage and utility in drug discovery
inferred← citeshttps://doi.org/10.1016/j.drudis.2008.04.003openalex-snapshot
Needed: system dynamics for the drug discovery process
inferred← citeshttps://doi.org/10.1016/j.drudis.2011.07.006openalex-snapshot
Structure-based drug design to augment hit discovery
inferred← citeshttps://doi.org/10.1016/j.proeng.2012.06.156openalex-snapshot
A Study on Cheminformatics and its Applications on Modern Drug Discovery
inferred← citeshttps://doi.org/10.1021/acs.jpcb.8b04509openalex-snapshot
Fragment Molecular Orbital Study of the Interaction between Sarco/Endoplasmic Reticulum Ca2+-ATPase and its Inhibitor Thapsigargin toward Anti-Malarial Development
inferred← citeshttps://doi.org/10.1038/s41467-023-41454-9openalex-snapshot
A pharmacophore-guided deep learning approach for bioactive molecular generation
inferred← citeshttps://doi.org/10.1038/s41589-024-01679-1openalex-snapshot
Machine learning in preclinical drug discovery
inferred← citeshttps://doi.org/10.1038/s43588-025-00850-5openalex-snapshot
Pharmacophore-oriented 3D molecular generation toward efficient feature-customized drug discovery
inferred← citeshttps://doi.org/10.1051/bioconf/202623202002openalex-snapshot
Deep learning on the fusion of chemical sequences and molecular grids for ligand-based virtual screening
inferred← citeshttps://doi.org/10.1089/adt.2006.4.209openalex-snapshot
Application of Laser-Scanning Fluorescence Microplate Cytometry in High Content Screening
inferred← citeshttps://doi.org/10.1093/bib/bbag548openalex-snapshot
MMP2Mol: a matched molecular pairs-based framework for ligand-based de novo drug design
inferred← citeshttps://doi.org/10.1109/bigcomp60711.2024.00050openalex-snapshot
Binding Affinity Prediction of the Radiolabeled PSMA-617 with PSMA via Graph Neural Network
inferred← citeshttps://doi.org/10.1145/2382936.2382944openalex-snapshot
Multi-target protein-chemical interaction prediction using task-regularized and boosted multi-task learning
inferred← citeshttps://doi.org/10.11606/t.76.2009.tde-23042009-145454openalex-snapshot
Planejamento racional de novos agentes quimioterápicos: Identificação e estudos cinéticos de novos inibidores da gliceraldeído-3-fosfato desidrogenase glicossomal de Trypanosoma cruzi
inferred← citeshttps://doi.org/10.1177/1087057109350114openalex-snapshot
High-Throughput Affinity-Based Technologies for Small-Molecule Drug Discovery
inferred← citeshttps://doi.org/10.1177/1087057114561950openalex-snapshot
Emergence of Chinese Drug Discovery Research: Impact of Hit and Lead Identification
inferred← citeshttps://doi.org/10.1177/2211068215623048openalex-snapshot
Consolidating a Distributed Compound Management Capability into a Single Installation: The Application of Overall Equipment Effectiveness to Determine Capacity Utilization
inferred← citeshttps://doi.org/10.1371/journal.pntd.0007633openalex-snapshot
Characterization of Entamoeba histolytica adenosine 5′-phosphosulfate (APS) kinase; validation as a target and provision of leads for the development of new drugs against amoebiasis
inferred← citeshttps://doi.org/10.1533/9780857097040.2.231openalex-snapshot
Microfluidic devices for drug discovery and analysis
inferred← citeshttps://doi.org/10.2147/rrmc.s28211openalex-snapshot
In silico investigation of functional nsSNPs – an approach to rational drug design
inferred← citeshttps://doi.org/10.2174/1570180820666230505124327openalex-snapshot
The Implication of Fragment-centric Mapping Strategy to Explore the First Selective Inhibitor Against Target Protein
inferred← citeshttps://doi.org/10.26686/wgtn.16971664openalex-snapshot
ParA: A Novel Target for Anti-Tubercular Drug Discovery
inferred← citeshttps://doi.org/10.26686/wgtn.16971664.v1openalex-snapshot
ParA: A Novel Target for Anti-Tubercular Drug Discovery
inferred← citeshttps://doi.org/10.26686/wgtn.17003413openalex-snapshot
Evaluation of Different Mycobacterial Species for Drug Discovery and Characterisation of Novel Inhibitors of Mycobacterium Tuberculosis
inferred← citeshttps://doi.org/10.26686/wgtn.17003413.v1openalex-snapshot
Evaluation of Different Mycobacterial Species for Drug Discovery and Characterisation of Novel Inhibitors of Mycobacterium Tuberculosis
inferred← citeshttps://doi.org/10.52540/2074-9457.2026.1.72openalex-snapshot
APPLICATION OF MACHINE LEARNING METHODS IN EARLY DRUG DEVELOPMENT
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.